Students much review the case study and answer all questions with a scholarly response using APA and include 2 scholarly references less tha 5 years. Need get 0 % plagiarism
APA format, double spaced, 3 pages, in text citations, and 4 references. One of the references must come from the book. (Information is attached).
Max Points: 150
Details:
Rate yourself using the results from the “Nurse Manager Skills Inventory”:
http://www.aone.org/resources/nurse-manager-skills-inventory.pdf
Write a reflection of 750-1,000 words in which you identify your strengths and weaknesses related to the four content areas below:
Discuss how you will use your current leadership skill set to advocate for change in your workplace.
Identify one personal goal for your leadership growth and discuss your implementation plan to achieve that goal.
While APA format is not required for the body of this assignment, solid academic writing is expected and in-text citations and references should be presented using APA documentation guidelines, which can be found in the APA Style Guide, located in the Student Success Center.
This assignment uses a rubric. Please review the rubric prior to beginning the assignment to become familiar with the expectations for successful completion.
You are required to submit this assignment to Turnitin. Please refer to the directions in the Student Success Center.
Critical Thinking Questions
1. What is the cardinal sign of Lyme disease? (always on the boards) 2. At what stages of Lyme disease are the IgG and IgM antibodies elevated? 3. Why was the ESR elevated? 4. What is the Therapeutic goal for Lyme Disease and what is the recommended treatment.
1. What is the cardinal sign of Lyme disease? (always on the boards)
2. At what stages of Lyme disease are the IgG and IgM antibodies elevated?
3. Why was the ESR elevated?
4. What is the Therapeutic goal for Lyme Disease and what is the recommended treatment.
Students much review the case study and answer all questions with a scholarly response using APA and include 2 scholarly references. Answer both case studies on the same document.
Case Studies will be uploaded to Moodle and put through TURN-It-In (anti-Plagiarism program)
1 What is the cardinal sign of Lyme Disease?
2 At what stages of Lyme Disease are the IgG and IgM antibodies elevated?
3 Why was the ESR elevated?
4 What id the therapeutic goal for Lyme Disease and what is the recommended treatment?
1 What was the cause of this patient pain and cramping?
2 Why was there decreased hair on the patient right leg?
3 What would be the strategic physical assessments after surgery to determine the adequacy of the patient circulation?
4 What would be the treatment of intermittent claudication for non occlusion?
Lyme Disease Case Study
A 38-year-old male had a 3-week history of fatigue and lethargy with intermittent complaints of headache, fever, chills, myalgia, and arthralgia. According to the history, the patient’s symptoms began shortly after a camping vacation. He recalled a bug bite and rash on his thigh immediately after the trip. The following studies were ordered:
Studies
Results
Lyme disease test,
Elevated IgM antibody titers against Borrelia burgdorferi (normal: low)
Erythrocyte sedimentation rate (ESR),
30 mm/hour (normal: ≤15 mm/hour)
Aspartate aminotransferase (AST),
32 units/L (normal: 8-20 units/L)
Hemoglobin (Hgb),
12 g/dL (normal: 14-18 g/dL)
Hematocrit (Hct),
36% (normal: 42%-52%)
Rheumatoid factor (RF),
Negative (normal: negative)
Antinuclear antibodies (ANA),
Negative (normal: negative)
Diagnostic Analysis
Based on the patient’s history of camping in the woods and an insect bite and rash on the thigh, Lyme disease was suspected. Early in the course of this disease, testing for specific immunoglobulin (Ig) M antibodies against B. burgdorferi is the most helpful in diagnosing Lyme disease. An elevated ESR, increased AST levels, and mild anemia are frequently seen early in this disease. RF and ANA abnormalities are usually absent.
Critical Thinking Questions
1. What is the cardinal sign of Lyme disease? (always on the boards)
2. At what stages of Lyme disease are the IgG and IgM antibodies elevated?
3. Why was the ESR elevated?
4. What is the Therapeutic goal for Lyme Disease and what is the recommended treatment.
Students much review the case study and answer all questions with a scholarly response using APA and include 2 scholarly references. Answer both case studies on the same document and upload 1 document to Moodle.
Case Studies will be uploaded to Moodle and put through TURN-It-In (anti-Plagiarism program)
Lyme Disease Case Study A 38-year-old male had a 3-week history of fatigue and lethargy with intermittent complaints of headache, fever, chills, myalgia, and arthralgia. According to the history, the patient’s symptoms began shortly after a camping vacation. He recalled a bug bite and rash on his thigh immediately after the trip.
The following studies were ordered: Studies Results Lyme disease test, Elevated IgM antibody titers against Borrelia burgdorferi (normal: low) Erythrocyte sedimentation rate (ESR), 30 mm/hour (normal: ≤15 mm/hour) Aspartate aminotransferase (AST), 32 units/L (normal: 8-20 units/L) Hemoglobin (Hgb), 12 g/dL (normal: 14-18 g/dL) Hematocrit (Hct), 36% (normal: 42%-52%) Rheumatoid factor (RF), Negative (normal: negative) Antinuclear antibodies (ANA), Negative (normal: negative) Diagnostic Analysis Based on the patient’s history of camping in the woods and an insect bite and rash on the thigh, Lyme disease was suspected. Early in the course of this disease, testing for specific immunoglobulin (Ig) M antibodies against B. burgdorferi is the most helpful in diagnosing Lyme disease. An elevated ESR, increased AST levels, and mild anemia are frequently seen early in this disease. RF and ANA abnormalities are usually absent. Critical Thinking Questions 1. What is the cardinal sign of Lyme disease? (always on the boards)
2. At what stages of Lyme disease are the IgG and IgM antibodies elevated?
3. Why was the ESR elevated?
4. What is the Therapeutic goal for Lyme Disease and what is the recommended treatment.
References:
Fouka, G. & Mantzorou, M. (2011). What are the Major Ethical Issues in Conducting Research?
Is there a Conflict between the Research Ethics and the Nature of Nursing? Health Science Journal, 5(1), 3-14.
Furuya, Y., Dick, A., Perencevich, E., Pogorzelska, M., Goldman, D., & Stone, P. (2011). Central line bundle implementation in US intensive care units and impact on bloodstream infections. PLoS ONE, 6(1), 1-6.
Graling, P., & Vasaly, F. (2013). The effectiveness of 2% CHG Cloth Bathing for Reducing Surgical Site Infections. AORN Journal, 97(5): 547-551.
Jeanes, A., & Bitmead, J. (2015) Reducing bloodstream infection with a chlorhexidine gel IV dressing. British Journal of Nursing, 24, S14-S19.
Kim, J., Holtom, P., & Vigen, C. (2011). Reduction of catheter-related bloodstream infections through the use of a central venous line bundle: Epidemiologic and economic consequences. American Journal of Infection Control, 39(8), 640-646.
Klinworth, G., Stafford, J., O’Connor, M., Leong, T., Hamley, L., Watson, K., Kennon, J., Bass, P., Cheng, A. C., & Worth, L. (2014). Implementation of a successful hospital-wide initiative to reduce central line–associated bloodstream infections. American Journal of Infection Control, 42(6), 685-687.
Kramer, N. (2016). Monitoring Central Line-Associated Bloodstream Infections [CLABSI] in Home Infusion. Infusion, 22(4), 35-44.
McAlearney, A., Hefner, J., Robbins, J., Harrison, M., & Garman, A. (2013). Preventing central line-associated bloodstream infections: A Qualitative Study of Management Practices. Infection Control & Hospital Epidemiology, 36(5), 557-563.
Mermel, L. (2014). MRSA and CLABSI Compendium updates offer additional focus on implementation. Patient Safety Monitor Journal, 15(9), 1-4.
Power, J., Peed, J., Burns, L., & Davis, M. (2012). Chlorhexidine bathing and microbial contamination in patients’ basin. American Journal of Critical Care, 21(5), 338-342.
Pyrek, K. (2015). Experts Address the Promise and Challenges of CHG Bathing Interventions. Infection Control Today, 19(1), 32-36.
Quach, C., Milstone, A, Perpe, C., Bonenfant, M., Moore, D., & Perreault, T. (2014). Chlorhexidine Bathing in a tertiary care neonatal intensive care unit: Impact on central line–associated bloodstream infections. Infection Control & Hospital Epidemiology, 35(2), 158-163.
Richardson, J., & Tjoelker, R. (2012). Beyond the central line-associated bloodstream infection bundle: the value of the clinical nurse specialist in continuing evidence-based practice changes. The Journal of Advanced Nursing Practice, 26(4), 205-211.
Sandoval, C. (2015). Three practice bundles to reduce CLABSIs. American Nurse Today, 10(11), 37-38.
Scheithauer, S., Lewalter, K., Schroder, J., Koch, A., Hafner, H., Krizanovic, V., Nowicki, K., Hilgers, R.-D., & Lemmen, S. (2014). Reduction of central venous line-associated bloodstream infection rates by using a chlorhexidine-containing dressing. Infection, 42(1), 155-159.
Wilder, K. A., Wall, B. Haggard, D. & Epperson, T. (2016). CLABSI Reduction Strategy: A Systematic Central Line Quality Improvement Initiative Integrating Line-Rounding Principles and a Team Approach. Advances in Neonatal Care, 16(3), 170-177.
U.S. Department of Health and Human Services. (2011). Health-care-associated infection (HAI). Retrieved 10/21/2016 from http://www.hhs.gov/ash/initiatives/hai/index.html
References:
Fouka, G. & Mantzorou, M. (2011). What are the Major Ethical Issues in Conducting Research?
Is there a Conflict between the Research Ethics and the Nature of Nursing? Health Science Journal, 5(1), 3-14.
Furuya, Y., Dick, A., Perencevich, E., Pogorzelska, M., Goldman, D., & Stone, P. (2011). Central line bundle implementation in US intensive care units and impact on bloodstream infections. PLoS ONE, 6(1), 1-6.
Graling, P., & Vasaly, F. (2013). The effectiveness of 2% CHG Cloth Bathing for Reducing Surgical Site Infections. AORN Journal, 97(5): 547-551.
Jeanes, A., & Bitmead, J. (2015) Reducing bloodstream infection with a chlorhexidine gel IV dressing. British Journal of Nursing, 24, S14-S19.
Kim, J., Holtom, P., & Vigen, C. (2011). Reduction of catheter-related bloodstream infections through the use of a central venous line bundle: Epidemiologic and economic consequences. American Journal of Infection Control, 39(8), 640-646.
Klinworth, G., Stafford, J., O’Connor, M., Leong, T., Hamley, L., Watson, K., Kennon, J., Bass, P., Cheng, A. C., & Worth, L. (2014). Implementation of a successful hospital-wide initiative to reduce central line–associated bloodstream infections. American Journal of Infection Control, 42(6), 685-687.
Kramer, N. (2016). Monitoring Central Line-Associated Bloodstream Infections [CLABSI] in Home Infusion. Infusion, 22(4), 35-44.
McAlearney, A., Hefner, J., Robbins, J., Harrison, M., & Garman, A. (2013). Preventing central line-associated bloodstream infections: A Qualitative Study of Management Practices. Infection Control & Hospital Epidemiology, 36(5), 557-563.
Mermel, L. (2014). MRSA and CLABSI Compendium updates offer additional focus on implementation. Patient Safety Monitor Journal, 15(9), 1-4.
Power, J., Peed, J., Burns, L., & Davis, M. (2012). Chlorhexidine bathing and microbial contamination in patients’ basin. American Journal of Critical Care, 21(5), 338-342.
Pyrek, K. (2015). Experts Address the Promise and Challenges of CHG Bathing Interventions. Infection Control Today, 19(1), 32-36.
Quach, C., Milstone, A, Perpe, C., Bonenfant, M., Moore, D., & Perreault, T. (2014). Chlorhexidine Bathing in a tertiary care neonatal intensive care unit: Impact on central line–associated bloodstream infections. Infection Control & Hospital Epidemiology, 35(2), 158-163.
Richardson, J., & Tjoelker, R. (2012). Beyond the central line-associated bloodstream infection bundle: the value of the clinical nurse specialist in continuing evidence-based practice changes. The Journal of Advanced Nursing Practice, 26(4), 205-211.
Sandoval, C. (2015). Three practice bundles to reduce CLABSIs. American Nurse Today, 10(11), 37-38.
Scheithauer, S., Lewalter, K., Schroder, J., Koch, A., Hafner, H., Krizanovic, V., Nowicki, K., Hilgers, R.-D., & Lemmen, S. (2014). Reduction of central venous line-associated bloodstream infection rates by using a chlorhexidine-containing dressing. Infection, 42(1), 155-159.
Wilder, K. A., Wall, B. Haggard, D. & Epperson, T. (2016). CLABSI Reduction Strategy: A Systematic Central Line Quality Improvement Initiative Integrating Line-Rounding Principles and a Team Approach. Advances in Neonatal Care, 16(3), 170-177.
U.S. Department of Health and Human Services. (2011). Health-care-associated infection (HAI). Retrieved 10/21/2016 from http://www.hhs.gov/ash/initiatives/hai/index.html
Hi there! Click one of our representatives below and we will get back to you as soon as possible.